Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial.
Christine Field, William A Grobman, Devra Mast...
https://pubmed.ncbi.nlm.nih.gov/41842598Actively Recruiting
Phase Not Applicable
Age: 18Years +
FEMALE
ID05909046
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) - Follow up Study: Patient Perspectives on Postpartum Interventions to Improve Future Maternal Cardiovascular Health After Gestational Diabetes (PP CARE)
Led by Ohio State University · Updated on 2025-11-24
104
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating postpartum diabetes screening methods and cardiovascular health counseling for individuals who experienced gestational diabetes during pregnancy. The study compares immediate inpatient postpartum oral glucose tolerance testing (OGTT) before hospital discharge to the current standard outpatient OGTT performed 4-12 weeks after delivery. Additionally, the study explores patient perspectives on postpartum cardiovascular health counseling and risk reduction, including social and structural factors that affect health outcomes. This research is conducted to address the increased risk of type 2 diabetes and cardiovascular disease in this population and to improve postpartum care. The trial includes two study groups: one receiving an immediate inpatient 2-hour OGTT before discharge, and the other receiving the standard 4-12 week outpatient OGTT. Eligible participants are individuals aged 18 or older, diagnosed with gestational diabetes during pregnancy, and receiving prenatal and postpartum care at the study site. A follow-up phase involves surveys and qualitative assessments between 12 and 24 months postpartum to evaluate barriers and facilitators of cardiovascular health counseling and wellness interventions. Participants will undergo diabetes screening either immediately postpartum or during the standard postpartum visit, with data collected on screening rates up to 12 weeks after delivery. Patient-reported outcomes on cardiovascular health counseling will be gathered within 12 months postpartum, while patient perspectives on postpartum interventions will be assessed between 12 and 24 months postpartum. The study measures include diabetes screening rates, cardiovascular counseling experiences, lifestyle changes, primary care visits, and diabetes treatment satisfaction. This research helps identify ways to improve postpartum screening and cardiovascular health management for individuals with gestational diabetes.
CONDITIONS
Brief Title
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
- Immediately postpartum individuals during their delivery hospital admission
- 18 years old or older with the ability to give informed consent
- Diagnosed with gestational diabetes during pregnancy by elevated glucose tests and provider documentation
- English or Spanish speaking
- Receiving prenatal and postpartum care at Ohio State University
You will not qualify if you...
- Cannot tolerate a 2-hour oral glucose tolerance test (e.g., history of gastric bypass)
- Not English or Spanish speaking
- For PP CARE follow-up, Spanish speaking participants are excluded due to study team language limitations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - During delivery hospital admission
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diabetes Screening
Duration - From delivery to up to 12 weeks postpartum
Participants undergo diabetes screening either immediately postpartum with a 2-hour oral glucose tolerance test (OGTT) before hospital discharge or the standard 4-12 week outpatient postpartum OGTT.
1 to 2 visits depending on assigned group (immediate inpatient or outpatient OGTT)
Postpartum Cardiovascular Health Follow-up
Duration - Within 12 to 24 months postpartum
Participants provide feedback on postpartum cardiovascular health counseling and share perspectives on interventions to improve future maternal cardiovascular health after gestational diabetes.
Follow-up contacts within 12 to 24 months postpartum
Trial Site Locations
Total: 1 location
1
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, United States, 43210
Actively Recruiting
Loading map...
Research Team
K
Kartik Venkatesh, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here